Ruben Kowalyszyn

3PUBLICATIONS
40CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 23, 2025
Treatment Trends in Metastatic Renal Clear Cell Carcinoma in Argentina.

Federico Cayol, Gabriela Gatica, Pablo Companys

|Feb 21, 2024
First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial.

Yelena Y Janjigian, Jaffer A Ajani, Markus Moehler

|Sep 15, 2023
Health-Related Quality of Life With Nivolumab Plus Chemotherapy Versus Chemotherapy in Patients With Advanced Gastric/Gastroesophageal Junction Cancer or Esophageal Adenocarcinoma From CheckMate 649.

Markus Moehler, Hong Xiao, Steven I Blum

Pageof 1

Frequent Collaborators

2 joint publications

Markus Moehler

2 joint publications

Kohei Shitara

2 joint publications

Yelena Y Janjigian

2 joint publications

Marcelo Garrido